Valérie Laurent-Matha

Jan 21, 2025 | bpspubs.onlinelibrary.wiley.com | Timothée David |ICM Montpellier France |Aude Mallavialle |Valérie Laurent-Matha

CONFLICT OF INTEREST STATEMENT No potential conflicts of interest were disclosed by all authors. Supporting Information Filename Description bph17437-sup-0001-Supporting_Information.pdfPDF document, 1.5 MB Figure S1. Immunotherapy of TNBC with the F1 anti-cathepsin-D antibody. Figure S2. Immunotherapy with anti-cathepsin-D antibodies triggers both innate and adaptive antitumour immunity in an immunocompetent mouse model of triple-negative breast cancer (TNBC). Figure S3.